---
figid: PMC3918721__TSWJ2014-521754.001
figtitle: TGFB signaling and MMPs interplay
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Oryctolagus cuniculus
- Mouse mammary tumor virus
pmcid: PMC3918721
filename: TSWJ2014-521754.001.jpg
figlink: /pmc/articles/PMC3918721/figure/fig1/
number: F1
caption: 'TGF-β signaling and MMPs interplay. Active TGF-β binds to its cell-surface
  type II receptor (TBRII), inducing the activation of TGF-β type I receptor (ALK5
  or TBRI) and forming a heterotetrameric complex. Then two sets of signaling pathways
  can be stimulated: the Smad pathway, where ALK5 phosphorylates Smad2,3 and promotes
  the release of Smads from the complex with SARA from the inner face of the plasma
  membrane (phosphorylated Smad2,3 interact with co-Smad4, forming a heteromeric complex
  to be translocated into the cell nucleus) and non-Smad pathways, where active TGF-β-receptor
  complex interacts with ubiquitin ligase tumor necrosis factor receptor-associated
  factor 6 (TRAF6) which in turn recruits TGF-β activated kinase 1 (TAK1) to activate
  p38, JNK, or NFκB pathway. On the other hand, TGF-β binding provokes the phosphorylation
  of ALK5 at tyrosine residues which enable the formation of Shc-Grb2/SoS complex
  to activate Ras-Raf1-MEK1,2-ERK1,2 signaling. Finally, receptor activated complexes
  can activate PI3K, provoking the activation of AKT and the small Rho GTPases. The
  activation of both Smad and non-Smad signaling pathways in turn initiate transcriptional
  or nontranscriptional activity to regulate MMPs expression, thus incrementing the
  protein levels in tumor microenvironment. When membrane bound MMPs or soluble MMPs
  are expressed, they may promote the activation of latent TGF-β by proteolytic cleavage
  within the N-terminal region of the latency-associated peptide (LAP) or the large
  latent complex (LLC).'
papertitle: 'Transforming Growth Factor-Beta and Matrix Metalloproteinases: Functional
  Interactions in Tumor Stroma-Infiltrating Myeloid Cells.'
reftext: Jelena Krstic, et al. ScientificWorldJournal. 2014;2014:521754.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8633472
figid_alias: PMC3918721__F1
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Oryctolagus cuniculus
redirect_from: /figures/PMC3918721__F1
ndex: 126330bd-df1c-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3918721__TSWJ2014-521754.001.html
  '@type': Dataset
  description: 'TGF-β signaling and MMPs interplay. Active TGF-β binds to its cell-surface
    type II receptor (TBRII), inducing the activation of TGF-β type I receptor (ALK5
    or TBRI) and forming a heterotetrameric complex. Then two sets of signaling pathways
    can be stimulated: the Smad pathway, where ALK5 phosphorylates Smad2,3 and promotes
    the release of Smads from the complex with SARA from the inner face of the plasma
    membrane (phosphorylated Smad2,3 interact with co-Smad4, forming a heteromeric
    complex to be translocated into the cell nucleus) and non-Smad pathways, where
    active TGF-β-receptor complex interacts with ubiquitin ligase tumor necrosis factor
    receptor-associated factor 6 (TRAF6) which in turn recruits TGF-β activated kinase
    1 (TAK1) to activate p38, JNK, or NFκB pathway. On the other hand, TGF-β binding
    provokes the phosphorylation of ALK5 at tyrosine residues which enable the formation
    of Shc-Grb2/SoS complex to activate Ras-Raf1-MEK1,2-ERK1,2 signaling. Finally,
    receptor activated complexes can activate PI3K, provoking the activation of AKT
    and the small Rho GTPases. The activation of both Smad and non-Smad signaling
    pathways in turn initiate transcriptional or nontranscriptional activity to regulate
    MMPs expression, thus incrementing the protein levels in tumor microenvironment.
    When membrane bound MMPs or soluble MMPs are expressed, they may promote the activation
    of latent TGF-β by proteolytic cleavage within the N-terminal region of the latency-associated
    peptide (LAP) or the large latent complex (LLC).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Sox2
  - Ltb
  - Tgfb1
  - Ltbp1
  - Acp2
  - Cebpb
  - elap
  - Acp3
  - Lap3
  - Cenpj
  - Tgfbr1
  - Tgfbr2
  - Sar1a
  - Zfyve9
  - ras
  - Hras
  - Kras
  - Rem1
  - Akt1
  - She
  - Zhx2
  - Pik3r1
  - Raf1
  - Ear1
  - Rho
  - Rhod
  - Ea2
  - Racgap1
  - Map2k2
  - Map2k1
  - Map2k3
  - Map2k6
  - Nfkb1
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - Mp
  - SNORD118
  - LTB
  - TGFB1
  - TGFB2
  - TGFB3
  - LAP
  - ACP2
  - PICALM
  - LAP3
  - CENPJ
  - PDON2
  - SMAD1
  - SMAD4
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - SMAD2
  - SMAD3
  - TGFBR1
  - TGFBR2
  - ZFYVE9
  - SAR1A
  - KRAS
  - HRAS
  - NRAS
  - XYLT2
  - SOS1
  - SOS2
  - AKT1
  - AKT2
  - AKT3
  - SHE
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - RNASE3
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - MAP2K2
  - MAP2K1
  - MAP2K3
  - MAP2K6
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - Pik3cg
  - Rnase2
  - Rela
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
